Skip to main content
Article
Allogeneic Hematopoietic Cell Transplantation for Chronic Myelomonocytic Leukemia: Relapse-Free Survival Is Determined by Karyotype and Comorbidities
Biology of Blood and Marrow Transplantation (2011)
  • Hesham Eissa, Baylor College of Medicine
  • Ted A. Gooley, Fred Hutchinson Cancer Research Center
  • Mohamed L. Sorror, Fred Hutchinson Cancer Research Center
  • Franchesca Nguyen, Fred Hutchinson Cancer Research Center
  • Bart L. Scott, Fred Hutchinson Cancer Research Center
  • Kristine Doney, Fred Hutchinson Cancer Research Center
  • Keith R. Loeb, Fred Hutchinson Cancer Research Center
  • Paul J. Martin, Fred Hutchinson Cancer Research Center
  • John M. Pagel, Fred Hutchinson Cancer Research Center
  • Jerry P. Radich, Fred Hutchinson Cancer Research Center
  • Brenda M. Sandmaier, Fred Hutchinson Cancer Research Center
  • E. Houston Warren, Fred Hutchinson Cancer Research Center
  • Rainer Storb, Fred Hutchinson Cancer Research Center
  • Frederick R. Appelbaum, Fred Hutchinson Cancer Research Center
  • H. Joachim Deeg, Fred Hutchinson Cancer Research Center
Publication Date
January 6, 2011
DOI
10.1016/j.bbmt.2010.09.018
Citation Information
Hesham Eissa, Ted A. Gooley, Mohamed L. Sorror, Franchesca Nguyen, et al.. "Allogeneic Hematopoietic Cell Transplantation for Chronic Myelomonocytic Leukemia: Relapse-Free Survival Is Determined by Karyotype and Comorbidities" Biology of Blood and Marrow Transplantation Vol. 17 Iss. 6 (2011) p. 908 - 915
Available at: http://works.bepress.com/john-pagel/181/